A review of life science current events reported by MedCity News this week:
A pharmacist’s hard lesson: “Don’t be another Eric Cropp.” Eric Cropp is a 42-year-old convicted felon living in suburban Cleveland who may have a tough time finding a job in the future. But the ex-pharmacist whose case led to “Emily’s Law” isn’t hiding from any of that, and he’s admirably candid about the events surrounding the Emily Jerry case. And that candor has resonated among many of his fellow pharmacists.
New cigarette warning labels go graphic. Tobacco warnings on cigarette packages are already hard to miss, but soon they’ll be impossible to ignore.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
GSK HIV drug pipeline sees boost as partner Concert steers to clinical trials. A strategic alliance GlaxoSmithKline (NYSE:GSK) entered into with partner Concert Pharmaceuticals now has a lead drug candidate – a possible new treatment for HIV. Concert’s selection of CTP-298 as the lead drug candidate means a $4 million milestone payment will go to the Lexington, Massachusetts-based biotechnology company.
Best Buy invests in N.C. mobile fitness earbud technology; leads $5.5M round. Valencell has developed earbuds that have the technology to track physiological metrics such as heart rate, calories burned, steps taken, distance traveled and speed. The data can be tracked in real time while the user listens to music or talks on the phone. Data can be streamed to smart phones or mp3 players through wired or wireless links, which would allow the user to use that personal information with training, coaching or fitness applications on mobile devices and online.
